News + Filings Transactions Holdings
|
Vivo Capital IX, LLC
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/09/2023 | IO Biotech, Inc. | | Purchase | Warrants (Right to Buy) | 3.2M | $2.47 | $7.8M | By Vivo Opportunity Fund Holdings, L.P. | 08/09/2023 |
| 08/09/2023 | IO Biotech, Inc. | | Purchase | Common Stock | 3.2M | $1.90 | $6M | By Vivo Opportunity Fund Holdings, L.P. | 08/09/2023 |
| 05/04/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 19.7k | $12.67 | $250.1k | See Footnote | 05/02/2022 |
| 05/03/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 451.4k | $13.25 | $6M | See Footnote | 05/02/2022 |
| 05/02/2022 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 41.8k | $15.19 | $634.9k | See Footnote | 05/02/2022 |
| 11/09/2021 | IO Biotech, Inc. | | Conversion | Common Stock | 2.4M | $0.00 | $0 | | 11/09/2021 |
| 11/09/2021 | IO Biotech, Inc. | | Purchase | Common Stock | 650k | $14.00 | $9.1M | | 11/09/2021 |
| 11/09/2021 | IO Biotech, Inc. | | Conversion | Series C Preferred Stock | 188.2k | $0.00 | $0 | | 11/09/2021 |
| 06/25/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 7.7k | $29.60 | $228k | See Footnote | 06/23/2021 |
| 06/24/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 10k | $29.90 | $299k | See Footnote | 06/23/2021 |
| 06/23/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 38k | $29.80 | $1.1M | See Footnote | 06/23/2021 |
| 06/22/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 110k | $28.50 | $3.1M | See Footnote | 06/21/2021 |
| 06/21/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 91.6k | $29.70 | $2.7M | See Footnote | 06/21/2021 |
| 04/14/2021 | Tarsus Pharmaceuticals, Inc. | | Sale | Common Stock | 400 | $30.37 | $12.1k | See Footnote | 04/14/2021 |
| 03/23/2021 | Instil Bio, Inc. | TIL | Conversion | Common Stock | 477.1k | $0.00 | $0 | | 03/23/2021 |
| 03/23/2021 | Instil Bio, Inc. | TIL | Purchase | Common Stock | 300k | $20.00 | $6M | | 03/23/2021 |
| 03/23/2021 | Instil Bio, Inc. | TIL | Conversion | Series B Preferred Stock | 9.8M | $0.00 | $0 | | 03/23/2021 |
| 03/23/2021 | Instil Bio, Inc. | TIL | Conversion | Series C Preferred Stock | 397.6k | $0.00 | $0 | | 03/23/2021 |
| 03/23/2021 | Instil Bio, Inc. | TIL | Conversion | Common Stock | 11.7M | $0.00 | $0 | | 03/23/2021 |
| 10/20/2020 | Tarsus Pharmaceuticals, Inc. | | Conversion | Common Stock | 2.8M | $0.00 | $0 | | 10/20/2020 |
| 10/20/2020 | Tarsus Pharmaceuticals, Inc. | | Conversion | Common Stock | 214.3k | $0.00 | $0 | | 10/20/2020 |
| 10/20/2020 | Tarsus Pharmaceuticals, Inc. | | Purchase | Common Stock | 250k | $16.00 | $4M | | 10/20/2020 |
| 10/20/2020 | Tarsus Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 2.8M | $0.00 | $0 | | 10/20/2020 |
| 10/20/2020 | Tarsus Pharmaceuticals, Inc. | | Conversion | Series C Preferred Stock | 214.3k | $0.00 | $0 | | 10/20/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Purchase | Common Stock | 789.5k | $19.00 | $15M | See footnote | 07/21/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Conversion | Common Stock | 3.2M | $0.00 | $0 | See footnote | 07/21/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Purchase | Common Stock | 185.5k | $19.00 | $3.5M | See footnote | 07/21/2020 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Conversion | Series C Convertible Preferred Stock | 3.2M | $0.00 | $0 | See footnote | 07/21/2020 |
|